Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A centralized Locations section is added with state subsections for California, Florida, North Carolina, Pennsylvania, and Texas. The previous standalone state location blocks and the HHS Vulnerability Disclosure link are removed.
    Difference
    0.6%
    Check dated 2025-12-17T19:48:01.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Publications section updated to indicate that PubMed publications are automatically filled and may not be about the study. The page revision now shows 'Revision: v3.3.2' and the previous wording with 'Revision: v3.2.0' was removed.
    Difference
    0.1%
    Check dated 2025-11-26T13:56:53.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page; this is a non-significant change that does not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:41:57.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The changes appear to be cosmetic: the page's layout/formatting has been updated, but there is no visible modification to core study details such as title, objectives, design, outcomes, eligibility criteria, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:20:22.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T16:10:45.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T10:14:24.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.